These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11495350)

  • 1. A direct chemical interaction between dynorphin and excitatory amino acids.
    Woods A; Zangen A
    Neurochem Res; 2001 Apr; 26(4):395-400. PubMed ID: 11495350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of peptide--peptide interaction by matrix-assisted laser desorption/ionization.
    Woods AS; Huestis MA
    J Am Soc Mass Spectrom; 2001 Jan; 12(1):88-96. PubMed ID: 11142364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin A elicits an increase in intracellular calcium in cultured neurons via a non-opioid, non-NMDA mechanism.
    Tang Q; Lynch RM; Porreca F; Lai J
    J Neurophysiol; 2000 May; 83(5):2610-5. PubMed ID: 10805661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity analysis of dynorphin A toxicity in spinal cord neurons: intrinsic neurotoxicity of dynorphin A and its carboxyl-terminal, nonopioid metabolites.
    Hauser KF; Knapp PE; Turbek CS
    Exp Neurol; 2001 Mar; 168(1):78-87. PubMed ID: 11170722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynorphin A toxicity in striatal neurons via an alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor mechanism.
    Goody RJ; Martin KM; Goebel SM; Hauser KF
    Neuroscience; 2003; 116(3):807-16. PubMed ID: 12573721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of NMDA receptor-mediated responses by dynorphin at low extracellular glycine concentrations.
    Zhang L; Peoples RW; Oz M; Harvey-White J; Weight FF; Brauneis U
    J Neurophysiol; 1997 Aug; 78(2):582-90. PubMed ID: 9307096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin block of N-methyl-D-aspartate channels increases with the peptide length.
    Chen L; Huang LY
    J Pharmacol Exp Ther; 1998 Mar; 284(3):826-31. PubMed ID: 9495839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-emptive dynorphin and N-methyl-D-aspartate glutamate receptor antagonism alters spinal immunocytochemistry but not allodynia following complete peripheral nerve injury.
    Wagner R; Deleo JA
    Neuroscience; 1996 May; 72(2):527-34. PubMed ID: 8737421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
    Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
    Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity interaction of (des-Tyrosyl)dynorphin A(2-17) with NMDA receptors.
    Tang Q; Gandhoke R; Burritt A; Hruby VJ; Porreca F; Lai J
    J Pharmacol Exp Ther; 1999 Nov; 291(2):760-5. PubMed ID: 10525097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-specific bioconversion of dynorphin neuropeptide detected by in situ histochemistry and MALDI imaging mass spectrometry.
    Bivehed E; Strömvall R; Bergquist J; Bakalkin G; Andersson M
    Peptides; 2017 Jan; 87():20-27. PubMed ID: 27840228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors.
    Laughlin TM; Vanderah TW; Lashbrook J; Nichols ML; Ossipov M; Porreca F; Wilcox GL
    Pain; 1997 Aug; 72(1-2):253-60. PubMed ID: 9272810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynorphin A (1-13) neurotoxicity in vitro: opioid and non-opioid mechanisms in mouse spinal cord neurons.
    Hauser KF; Foldes JK; Turbek CS
    Exp Neurol; 1999 Dec; 160(2):361-75. PubMed ID: 10619553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin A(1-17) biotransformation in striatum of freely moving rats using microdialysis and matrix-assisted laser desorption/ionization mass spectrometry.
    Reed B; Zhang Y; Chait BT; Kreek MJ
    J Neurochem; 2003 Aug; 86(4):815-23. PubMed ID: 12887680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression effects in enzymatic peptide ladder sequencing using ultraviolet - matrix assisted laser desorption/ionization - mass spectormetry.
    Kratzer R; Eckerskorn C; Karas M; Lottspeich F
    Electrophoresis; 1998 Aug; 19(11):1910-9. PubMed ID: 9740051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin uses a non-opioid mechanism to potentiate N-methyl-D-aspartate currents in single rat periaqueductal gray neurons.
    Lai SL; Gu Y; Huang LY
    Neurosci Lett; 1998 May; 247(2-3):115-8. PubMed ID: 9655606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translocation of dynorphin neuropeptides across the plasma membrane. A putative mechanism of signal transmission.
    Marinova Z; Vukojevic V; Surcheva S; Yakovleva T; Cebers G; Pasikova N; Usynin I; Hugonin L; Fang W; Hallberg M; Hirschberg D; Bergman T; Langel U; Hauser KF; Pramanik A; Aldrich JV; Gräslund A; Terenius L; Bakalkin G
    J Biol Chem; 2005 Jul; 280(28):26360-70. PubMed ID: 15894804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of peptide-peptide interactions using MALDI ion mobility o-TOF and ESI mass spectrometry.
    Woods AS; Koomen JM; Ruotolo BT; Gillig KJ; Russel DH; Fuhrer K; Gonin M; Egan TF; Schultz JA
    J Am Soc Mass Spectrom; 2002 Feb; 13(2):166-9. PubMed ID: 11838019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presynaptic modulation of glutamate and dynorphin release by excitatory amino acids in the guinea-pig hippocampus.
    Gannon RL; Terrian DM
    Neuroscience; 1991; 41(2-3):401-10. PubMed ID: 1678499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro biotransformation of dynorphin A (1-17) is similar in human and rhesus monkey blood as studied by matrix-assisted laser desorption/ionization mass spectrometry.
    Yu J; Butelman ER; Woods JH; Chait BT; Kreek MJ
    J Pharmacol Exp Ther; 1996 Nov; 279(2):507-14. PubMed ID: 8930152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.